Metabolic effects of an essential amino acid supplement in adolescents with PCOS and obesity.

What Was Tested

Researchers studied Copper (Supplement) in the context of pcos in this randomized controlled trial publication.

Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism, insulin resistance, and hepatic steatosis (HS).

Who Took Part

The study group was 21 adolescents.

PubMed indexes the participants as teenagers, women only.

How the Study Was Run

In design terms this was a randomized, double-blind, placebo-controlled and crossover study.

The adolescents were allocated by chance, so the Copper (Supplement) group and the comparison group should start out alike.

Neither the adolescents nor the staff measuring them knew who was on Copper (Supplement), so expectations could not easily colour the readings.

A placebo (an inactive look-alike) gave the Copper (Supplement) group a baseline to be compared against.

Each person switched between Copper (Supplement) and the comparison at some point, usually with a gap in between.

A randomized, double-blind, crossover, placebo-controlled trial was conducted in 21 adolescents with PCOS (BMI 37.3 ± 6.5 kg/m2, age 15.6 ± 1.3 years).

Liver fat, very low-density lipoprotein (VLDL) lipogenesis, and triacylglycerol (TG) metabolism were measured following each 28-day phase of placebo or EAA.

What Was Measured

The subject headings attached to it are Fatty Liver, Hyperandrogenism, Insulin, Insulin Resistance, Lipoproteins, VLDL, Obesity and Polycystic Ovary Syndrome.

What This Means in Plain Language

The paper is a randomized, double-blind and placebo-controlled study of Copper (Supplement) in 21 adolescents in people with pcos.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 7 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 2024 (Obesity (Silver Spring, Md.)), a journal based in United States.

More context: the Copper (Supplement) compound page, PCOS research.